The Asston Pharmaceuticals Ltd IPO date has been confirmed from July 9, 2025, and closes on July 11, 2025. Read the post to learn about Asston Pharmaceuticals Ltd IPO GMP.
Asston Pharmaceuticals IPO is a bookbuilding of ₹27.56 crores. The issue is entirely a fresh issue of 22.41 lakh shares. Asston Pharmaceuticals IPO price band is set at ₹115 to ₹123 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,30,000 (2,000 shares). The minimum lot size investment for HNI is 3 lots (3,000 shares) amounting to ₹3,69,000.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
July 9-11Price Range
₹115 to ₹123 per shareFace Value
₹10 per shareGMP
₹10Asston Pharmaceuticals Ltd IPO GMP
The Asston Pharmaceuticals Ltd IPO GMP Today is ₹10.
IPO Overview
Asston Pharmaceuticals IPO opens for subscription on July 9, 2025 and closes on July 11, 2025. The allotment for the Asston Pharmaceuticals IPO is expected to be finalized on Monday, July 14, 2025. Asston Pharmaceuticals IPO will be list on BSE SME with a tentative listing date fixed as Wednesday, July 16, 2025.
Asston Pharmaceuticals Ltd IPO Details
| IPO Date | July 9, 2025 to July 11, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹115 to ₹123 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 22,41,000 shares (aggregating up to ₹27.56 Cr) |
| Reserved for Market Maker | 1,13,000 shares (aggregating up to ₹1.39 Cr)JSK Securities and Services Private Limited |
| Net Offered to Public | 21,28,000 shares (aggregating up to ₹26.17 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 62,71,360 shares |
| Share Holding Post Issue | 85,12,360 shares |
Asston Pharmaceuticals Ltd Financial Information
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Revenue | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| EBITDA | 1.93 | 6.16 | 2.55 | 1.52 |
| Net Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserves and Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.83 | 7.26 | 6.82 | 5.25 |
| Amount in ₹ Crore | ||||
Asston Pharmaceuticals Ltd IPO Timeline
| IPO Open Date | Wed, Jul 9, 2025 |
| IPO Close Date | Fri, Jul 11, 2025 |
| Tentative Allotment | Mon, Jul 14, 2025 |
| Initiation of Refunds | Tue, Jul 15, 2025 |
| Credit of Shares to Demat | Tue, Jul 15, 2025 |
| Tentative Listing Date | Wed, Jul 16, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 11, 2025 |
Company Profile
Established in 2019, Asston Pharmaceuticals Pvt. Ltd. is a fast-growing pharmaceutical company driven by a leadership team with over 25 years of industry experience. Founded by Dr. Ashish Sakalkar, Mrs. Saili More, and Mr. Sachin Badakh, our company is committed to delivering high-quality healthcare solutions across international markets. Specializing in a wide range of formulations—including tablets, capsules, sachets, and syrups—we focus on building a strong portfolio of branded and generic products. With a vision to be a global leader and a mission rooted in quality, innovation, and customer-centricity, Asston Pharmaceuticals is shaping a healthier tomorrow, one dose at a time.
Registrar Info
| Name | Maashitla Securities Private Limited |
| Phone number | +91-11-45121795-96 |
| Email ID | ipo@maashitla.com |
| Website | https://maashitla.com/allotment-status/public-issues |
Contact Details
| Name | Asston Pharmaceuticals Limited |
| Phone number | +91 22 49731411 |
| Email ID | info@asstonpharmaceuticals.com |
| Website | http://www.asstonpharmaceuticals.com/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Asston Pharmaceuticals Ltd IPO FAQs
When Asston Pharmaceuticals IPO will open?
The Asston Pharmaceuticals IPO opens on July 9, 2025 and closes on July 11, 2025.
What is the lot size of Asston Pharmaceuticals IPO?
Asston Pharmaceuticals IPO lot size is 1000, and the minimum amount required for application is ₹2,46,000, with 2 lots being the minimum application size.
When is Asston Pharmaceuticals IPO listing date?
The Asston Pharmaceuticals IPO listing date is not yet announced. The tentative date of Asston Pharmaceuticals IPO listing is Wednesday, July 16, 2025.
Leave a Reply